Latest Articles
Why More Working Women In Their 30s Are Being Diagnosed With Endometriosis - BW Healthcare World
Why More Working Women In Their 30s Are Being Diagnosed With Endometriosis BW Healthcare World
Published: May 19, 2026, 7:18 p.m.
An Unusual Diagnosis of Inguinal Pain in a Childbearing-Age Woman: An Inflamed Canal of Nuck Cyst With an Abnormal Leiomyomatous Proliferation - Cureus
An Unusual Diagnosis of Inguinal Pain in a Childbearing-Age Woman: An Inflamed Canal of Nuck Cyst With an Abnormal Leiomyomatous Proliferation Cureus
Published: May 19, 2026, 5:10 p.m.
Polycystic Ovary Syndrome (PCOS) Is Now PMOS - Black Health Matters
Polycystic Ovary Syndrome (PCOS) Is Now PMOS Black Health Matters
Published: May 19, 2026, 4:22 p.m.
Naomi Osaka Gets Candid About Motherhood, Pressure, and Learning to Ask for Help - Black Health Matters
Naomi Osaka Gets Candid About Motherhood, Pressure, and Learning to Ask for Help Black Health Matters
Published: May 19, 2026, 3:58 p.m.
Easing pain: Way to slash endometriosis diagnosis by years - Gold Coast Bulletin
Easing pain: Way to slash endometriosis diagnosis by years Gold Coast Bulletin
Published: May 19, 2026, 2:33 p.m.
Thank You For Signing Up | EndoFound SMS Updates - Endometriosis Foundation of America
Thank You For Signing Up | EndoFound SMS Updates Endometriosis Foundation of America
Published: May 19, 2026, 2:13 p.m.
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer - TradingView
KPTI: SENTRY and ECO42 trials highlight selinexor's promise in myelofibrosis and endometrial cancer TradingView
Published: May 19, 2026, 2 p.m.
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis - News-Medical
Cyclana Bio granted Health Research Authority approval and recruits first patients for clinical observational study in endometriosis News-Medical
Published: May 19, 2026, 12:42 p.m.
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer - BioSpace
Merck’s billion-dollar Kelun bet pays off as TROP2 improves survival in endometrial cancer BioSpace
Published: May 19, 2026, 11:19 a.m.
Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis - BioSpace
Cyclana Bio Granted Health Research Authority Approval and Recruits First Patients for Clinical Observational Study in Endometriosis BioSpace
Published: May 19, 2026, 11:15 a.m.
Link copied to clipboard!